https://veravas.com/news/ 2025-12-16T22:11:24+00:00 https://veravas.com/news/veravas-inc-joins-national-accelerator-to-advance-heart-and-brain-health/ 2025-12-16T22:11:24+00:00 https://veravas.com/news/verabind-tau-is-being-developed-jointly-with-veravas-inc-and-phanes-biotech-inc/ 2025-12-16T22:09:39+00:00 https://veravas.com/news/new-research-validating-verabind-tau-assay-as-accurate-blood-test-for-active-tau-pathology-in-alzheimers-disease-presented-at-the-2025-alzheimers-association-international-conference/ 2025-12-14T01:18:29+00:00 https://veravas.com/news/veravas-completes-analytical-verification-study-of-the-verabind-tau-assay-a-groundbreaking-test-to-measure-alzheimers-tau-pathology-in-blood/ 2025-12-14T01:04:41+00:00 https://veravas.com/news/veravas-improves-diagnostic-tests-by-purifying-samples/ 2025-12-14T01:04:06+00:00 https://veravas.com/news/veravas-launches-verabind-tau-first-blood-test-to-detect-alzheimers-related-tau-pathology/ 2025-12-14T01:03:22+00:00